Reaction
Leukocyturia reporting signals
As of the last recalculation, Leukocyturia appears in 815 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 128.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 87 | 128.5 | 129.1 |
| Dimenhydrinate | 27 | 66.9 | 67.1 |
| Cimetidine | 10 | 26.8 | 26.9 |
| Pyrazinamide | 6 | 16.4 | 16.4 |
| Dapagliflozin | 19 | 15.8 | 15.8 |
| Pemetrexed | 9 | 10.8 | 10.8 |
| Nirmatrelvir And Ritonavir | 6 | 2.8 | 2.8 |